CN1879852A - A gall stone-treating medicine - Google Patents
A gall stone-treating medicine Download PDFInfo
- Publication number
- CN1879852A CN1879852A CN 200610080016 CN200610080016A CN1879852A CN 1879852 A CN1879852 A CN 1879852A CN 200610080016 CN200610080016 CN 200610080016 CN 200610080016 A CN200610080016 A CN 200610080016A CN 1879852 A CN1879852 A CN 1879852A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- parts
- treatment
- cholelithiasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating gallstone which is prepared from the following raw material herbs including (by weight ratio) lysimachia christinae 40-60, cape jasmine 5-20, oriental wormwood 40-60, rhizoma corydalis 5-20, rhubarb horsetails 2-10, sodium sulfate 2-20 and curcuma aromatica 5-20.
Description
Affiliated technical field
The present invention relates to a kind of Chinese medicine, relating to a kind of specifically is the medicine of raw material treatment cholelithiasis with the Chinese herbal medicine.
Background technology
Cholecystitis, cholelithiasis are common diseases.The generation of most of cholecystitis all because of existing calculus in the gallbladder, has been blocked cystic duct, and it is not smooth that bile is discharged, and bacterial infection takes place then, forms cholecystitis.Cholelithiasis is that cholesterol occurs due to the crystallization under gallbladder fat acid and cholesterol situation out of proportion, and having only special circumstances is that the excretory bile of gallbladder flows to duodenum by bile duct, and duodenal antibacterial is back to gallbladder and forms infection.The disease symptom of cholelithiasis shows as Upper abdominal pain and emits to shoulder and back, and the low grade fever, feel sick, vomiting, shiver with cold, dripping sweat even with jaundice.Chronic cholecystitis and cholelithiasis are the predisposing factorss that carcinoma of gallbladder has, and gallbladder is subjected to the stimulation of cholic acid, choline in chronic inflammatory disease and the cholelithiasis for a long time, makes gallbladder mucosa generation canceration easily.Cholelithiasis women is more than the male, and pilosity is born in the obese women more than 40 years old.Chinese medicine is scattered in for the record of primary disease: in the diseases such as " gallbladder cardiopathia ", " side of body is sick ", " irritability disease ", " jaundice ".Primary disease is many because of eating and drinking without temperance, and cold warm not normal, feelings will is not smooth, invade in the exopathogen and bring out, liver happiness bar reaches, and gallbladder is the mansion of middle essence, main catharsis, Gu is seen hypochondriac pain, with the passing of time heat-transformation, warm penting up, falling ill is jaundice, but decocts then freestone of bile, if it is damp and hot flourishing, intense heat in both QI and blood systems, the danger time that positive exogenous pathogen falls into very then takes place in consumption of body fluid by heat.Cholelithiasis is one of commonly encountered diseases, and traditional Therapeutic Method is a surgical operation.Yet many patients wish and can eliminate cholelithiasis by enough non-operative treatments.Present western medical treatment can adopt the extracoporeal shock wave lithotripsy treatment, and the extracoporeal shock wave lithotripsy of utilizing liquid electricity, piezoelectricity or magnetoelectric effect to make can be passed people's skin and tissue at the external high energy shock wave that sends, and at stone location, calculus is pulverized energy accumulating.Though this Therapeutic Method has been exempted the damage to health of the misery of operation and excision gallbladder, but this lithotrite is not any cholelithiasis patient all can be used, have only calculus less, have many calculus, gallbladder function good and be radioparent calculus, can just can make treatment in this way by the calculus of the clear definite position of ultrasound investigation, treat by lithotrite, the calculus that also has can't smash, and need to take medicine for a long time after the treatment, this has increased the certain economic burden to patient, and takes medicine for a long time and also have certain side effect.
Summary of the invention
The object of the present invention is to provide a kind of litholytic effect good, short treating period, painful little, be free from side effects, to the undamaged a kind of medicine for the treatment of cholelithiasis of health.
Medicine of the present invention be the inventor based on motherland's medical science to the pathogenetic understanding of cholelithiasis, in line with the principle of clearing away heat-damp and promoting diuresis, promoting the circulation of QI to relieve pain, cholagogic and lithagogue, through clinical trial for many years, checking draws repeatedly.
If drug main of the present invention is made by following bulk drugs:
Herba Lysimachiae 40-60, Fructus Gardeniae 5-20, Herba Artemisiae Scopariae 40-60, Rhizoma Corydalis 5-20, Radix Et Rhizoma Rhei 2-10, Natrii Sulfas 2-20, Radix Curcumae 5-20.
The preferred ingredient of medicine of the present invention is (consumption is a weight portion):
Herba Lysimachiae 45-55, Fructus Gardeniae 8-15, Herba Artemisiae Scopariae 45-55, Rhizoma Corydalis 6-15, Radix Et Rhizoma Rhei 4-8, Natrii Sulfas 5-15, Radix Curcumae 8-15.
The optimum weight proportioning of medicine of the present invention is:
Herba Lysimachiae 50, Fructus Gardeniae 10, Herba Artemisiae Scopariae 50, Rhizoma Corydalis 10, Radix Et Rhizoma Rhei 5, Natrii Sulfas 5, Radix Curcumae 10.
In order to reach better curative effect, medicine of the present invention also comprises following bulk drugs:
Fructus Aurantii 5-20, Radix Aucklandiae 5-20, Radix Scutellariae 5-20.
Medicine of the present invention is that the preferred preferred weight part that reaches the crude drug of better curative effect adding is:
Fructus Aurantii 6-15, Radix Aucklandiae 8-15, Radix Scutellariae 6-15.
Medicine of the present invention is that the optimum weight part that reaches the crude drug of better curative effect adding is:
Fructus Aurantii 10, the Radix Aucklandiae 10, Radix Scutellariae 10.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any routine dosage form for oral administration, for example these crude drug pulverize mix homogeneously can be made powder and take after mixing it with water; These crude drug decoctings can be made decoction oral; Also can directly make the honeyed pill or the watered pill etc. with adding adjuvant after the raw material pulverizing.In order to make each crude drug better bring into play curative effect, preferably with in the crude drug except that Natrii Sulfas other each crude drug decoctings make decoction oral, the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
The instructions of taking of medicine of the present invention, medicine of the present invention can be decided according to patient's the body constitution and the state of an illness order of importance and emergency, and general every day, potion divided secondary oral, body shape prover can obey two doses, 7 days is a course of treatment, and the pain increased after the medication and loose stool is a drug effect, and the former may be the calculus symbol, should note observing the calculus phenomenon this moment, if take medicine for a long time, when influential, can be interrupted and take medicine appetite.
Beneficial effect of the present invention is: drug regimen of the present invention makes each medicine produce synergism, can effectively treat cholelithiasis.Herba Artemisiae Scopariae, Fructus Gardeniae, Radix Scutellariae, Herba Lysimachiae clearing away heat-damp and promoting diuresis in the drug component of the present invention, Fructus Aurantii, the Radix Aucklandiae, Rhizoma Corydalis, Radix Curcumae promoting the circulation of QI to relieve pain, Radix Et Rhizoma Rhei, Natrii Sulfas heat clearing away catharsis calculus.Medicine of the present invention is through clinical observation, and is better for less calculus or muddy stone curative effect, it is generally acknowledged to be adapted to: choledocholith, and diameter is less than 1 centimetre of person; Hepatobiliary sand like calculi; The remaining calculus of operation back biliary tract.Good analgesic effect of the present invention, within taking medicine back 7 days, most of patient's stomachache, low grade fever, feel sick, vomiting and jaundice etc. disappear or alleviate, calculus was discharged in 14 days, 3 courses of treatment of taking medicine, 79% patient can cure, though 12% patient does not cure, take a favorable turn.
Clinical observation of the present invention:
1, physical data
Accept patient's totally 42 examples for medical treatment, wherein male 14 examples, women 28 examples, age 18-52 year.
2, diagnostic criteria
Abdominal pain also emits to shoulder and back, the low grade fever is arranged, feels sick, vomiting, shiver with cold or with jaundice, calculus in the visible gallbladder of ultrasound investigation mostly.
3, Therapeutic Method
General every day, potion divided secondary oral, and 7 days is a course of treatment.
4, efficacy assessment standard
Produce effects: the symptom complete obiteration, ultrasound investigation does not have calculus.
Take a turn for the better: symptom is obviously alleviated.
Invalid: as not reach the improvement standard.
5, therapeutic outcome
| Produce effects | Take a turn for the better | Invalid | Effective percentage % | |||
| The example number | Obvious effective rate % | The example number | Improvement rate % | The example number | Inefficiency % | |
| 33 | 78.57 | 5 | 11.9 | 4 | 9.53 | 90.47 |
The specific embodiment
[embodiment 1]
Take by weighing raw material (gram) by following proportioning: Herba Lysimachiae 50, Fructus Gardeniae 10, Herba Artemisiae Scopariae 50, Rhizoma Corydalis 10, Radix Et Rhizoma Rhei 5, Natrii Sulfas 5, Radix Curcumae 10 is made decoction oral with Herba Lysimachiae, Fructus Gardeniae, Herba Artemisiae Scopariae, Rhizoma Corydalis, Radix Et Rhizoma Rhei, Radix Curcumae decocting, and the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
[embodiment 2]
Take by weighing raw material (gram) by following proportioning: Herba Lysimachiae 50, Fructus Gardeniae 10, Herba Artemisiae Scopariae 50, Rhizoma Corydalis 10, Fructus Aurantii 10, the Radix Aucklandiae 10, Radix Et Rhizoma Rhei 5, Radix Scutellariae 10, Natrii Sulfas 5, Radix Curcumae 10 is made decoction oral with Herba Lysimachiae, Fructus Gardeniae, Herba Artemisiae Scopariae, Rhizoma Corydalis, Fructus Aurantii, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Radix Scutellariae, Radix Curcumae decocting, and the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
[embodiment 3]
Take by weighing raw material (gram) by following proportioning: Herba Lysimachiae 45, Fructus Gardeniae 8, Herba Artemisiae Scopariae 45, Rhizoma Corydalis 6, Fructus Aurantii 6, the Radix Aucklandiae 8, Radix Et Rhizoma Rhei 4, Radix Scutellariae 6, Natrii Sulfas 5, Radix Curcumae 8.Herba Lysimachiae, Fructus Gardeniae, Herba Artemisiae Scopariae, Rhizoma Corydalis, Fructus Aurantii, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Radix Scutellariae, Radix Curcumae decocting are made decoction oral, the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
[embodiment 4]
Take by weighing raw material (gram) by following proportioning: Herba Lysimachiae 55, Fructus Gardeniae 15, Herba Artemisiae Scopariae 55, Rhizoma Corydalis 15, Fructus Aurantii 15, the Radix Aucklandiae 15, Radix Et Rhizoma Rhei 8, Radix Scutellariae 15, Natrii Sulfas 15, Radix Curcumae 15.Herba Lysimachiae, Fructus Gardeniae, Herba Artemisiae Scopariae, Rhizoma Corydalis, Fructus Aurantii, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Radix Scutellariae, Radix Curcumae decocting are made decoction oral, the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
[embodiment 5]
Take by weighing raw material (gram) by following proportioning: Herba Lysimachiae 40, Fructus Gardeniae 5, Herba Artemisiae Scopariae 40, Rhizoma Corydalis 5, Fructus Aurantii 5, the Radix Aucklandiae 5, Radix Et Rhizoma Rhei 2, Radix Scutellariae 5, Natrii Sulfas 2, Radix Curcumae 5.Herba Lysimachiae, Fructus Gardeniae, Herba Artemisiae Scopariae, Rhizoma Corydalis, Fructus Aurantii, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Radix Scutellariae, Radix Curcumae decocting are made decoction oral, the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
[embodiment 6]
Take by weighing raw material (gram) by following proportioning: Herba Lysimachiae 55, Fructus Gardeniae 15, Herba Artemisiae Scopariae 55, Rhizoma Corydalis 15, Fructus Aurantii 15, the Radix Aucklandiae 15, Radix Et Rhizoma Rhei 8, Radix Scutellariae 15, Natrii Sulfas 15, Radix Curcumae 15.Herba Lysimachiae, Fructus Gardeniae, Herba Artemisiae Scopariae, Rhizoma Corydalis, Fructus Aurantii, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Radix Scutellariae, Radix Curcumae decocting are made decoction oral, the Natrii Sulfas pulverize is taken after mixing it with water after finishing off decoction.
Claims (6)
1, a kind of medicine for the treatment of cholelithiasis is characterized in that: mainly be to be made by following bulk drugs: Herba Lysimachiae 40-60 part, Fructus Gardeniae 5-20 part, Herba Artemisiae Scopariae 40-60 part, Rhizoma Corydalis 5-20 part, Radix Et Rhizoma Rhei 2-10 part, Natrii Sulfas 2-20 part, Radix Curcumae 5-20 part.
2, a kind of medicine for the treatment of cholelithiasis according to claim 1, it is characterized in that: the weight portion of this medicine material medicine is: Herba Lysimachiae 45-55 part, Fructus Gardeniae 8-15 part, Herba Artemisiae Scopariae 45-55 part, Rhizoma Corydalis 6-15 part, Radix Et Rhizoma Rhei 4-8 part, Natrii Sulfas 5-15 part, Radix Curcumae 8-15 part.
3, a kind of medicine for the treatment of cholelithiasis according to claim 1 and 2, it is characterized in that: wherein the consumption of each crude drug is: 50 parts of Herba Lysimachiaes, 10 parts of Fructus Gardeniaes, 50 parts of Herba Artemisiae Scopariaes, 10 parts of Rhizoma Corydalis, 5 parts of Radix Et Rhizoma Rhei, 5 parts in Natrii Sulfas, 10 parts of Radix Curcumaes.
4, a kind of medicine for the treatment of cholelithiasis according to claim 1 is characterized in that: wherein also have following bulk drugs: Fructus Aurantii 5-20 part, Radix Aucklandiae 5-20 part, Radix Scutellariae 5-20 part.
5, a kind of medicine for the treatment of cholelithiasis according to claim 2 is characterized in that: wherein also have following bulk drugs: Fructus Aurantii 6-15 part, Radix Aucklandiae 8-15 part, Radix Scutellariae 6-15 part.
6, a kind of medicine for the treatment of cholelithiasis according to claim 3 is characterized in that: wherein also have following bulk drugs: 10 parts of Fructus Aurantiis, 10 parts of the Radix Aucklandiae, 10 parts of Radix Scutellariaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610080016 CN1879852A (en) | 2006-04-29 | 2006-04-29 | A gall stone-treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610080016 CN1879852A (en) | 2006-04-29 | 2006-04-29 | A gall stone-treating medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1879852A true CN1879852A (en) | 2006-12-20 |
Family
ID=37518353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610080016 Pending CN1879852A (en) | 2006-04-29 | 2006-04-29 | A gall stone-treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1879852A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658656B (en) * | 2009-09-20 | 2011-02-09 | 翟修祥 | Medicine for curing cholelithiasis |
| CN103251874A (en) * | 2012-02-15 | 2013-08-21 | 张文波 | Traditional Chinese medicine treating liver, gall lithiasis and complications and its making method |
| CN103463578A (en) * | 2013-09-25 | 2013-12-25 | 王滋东 | Medicament for treating cholelithiasis, cholecystitis and hyperbilirubinemia |
| CN104258308A (en) * | 2014-10-20 | 2015-01-07 | 刘锡庆 | Traditional Chinese medicine preparation for treating cholelithiasis |
| CN104758423A (en) * | 2015-04-22 | 2015-07-08 | 李丽丽 | Traditional Chinese medicine prescription for treating gallstone |
| CN104922328A (en) * | 2015-06-30 | 2015-09-23 | 赵德欣 | Traditional Chinese medicine composition for treating gall-stone and preparation method thereof |
| CN107569647A (en) * | 2017-07-21 | 2018-01-12 | 刘道鹏 | A kind of composition for treating gall stone and preparation method thereof |
-
2006
- 2006-04-29 CN CN 200610080016 patent/CN1879852A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658656B (en) * | 2009-09-20 | 2011-02-09 | 翟修祥 | Medicine for curing cholelithiasis |
| CN103251874A (en) * | 2012-02-15 | 2013-08-21 | 张文波 | Traditional Chinese medicine treating liver, gall lithiasis and complications and its making method |
| CN103463578A (en) * | 2013-09-25 | 2013-12-25 | 王滋东 | Medicament for treating cholelithiasis, cholecystitis and hyperbilirubinemia |
| CN103463578B (en) * | 2013-09-25 | 2015-04-29 | 王滋东 | Medicament for treating cholelithiasis, cholecystitis and hyperbilirubinemia |
| CN104258308A (en) * | 2014-10-20 | 2015-01-07 | 刘锡庆 | Traditional Chinese medicine preparation for treating cholelithiasis |
| CN104758423A (en) * | 2015-04-22 | 2015-07-08 | 李丽丽 | Traditional Chinese medicine prescription for treating gallstone |
| CN104922328A (en) * | 2015-06-30 | 2015-09-23 | 赵德欣 | Traditional Chinese medicine composition for treating gall-stone and preparation method thereof |
| CN107569647A (en) * | 2017-07-21 | 2018-01-12 | 刘道鹏 | A kind of composition for treating gall stone and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100998843A (en) | Medicinal composition for treating cholecystitis | |
| CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
| CN1751734A (en) | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method | |
| CN1879852A (en) | A gall stone-treating medicine | |
| CN102441081A (en) | Medicament for treating gout and its preparation method | |
| CN1244373C (en) | Chinese medicinal composition for cholecystitis and preparing method thereof | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN101468194B (en) | Medicine composition for treating colitis and method of making the same | |
| CN103251886A (en) | Chinese medicine for treating postpartum lochiorrhea and preparation method thereof | |
| CN104189759A (en) | Traditional Chinese medicine composition for treating cholelithiasis | |
| CN103638456B (en) | A kind of Chinese medicine for the treatment of liver cirrhosis and preparation method thereof | |
| CN1314443C (en) | Medicine for treating different diseases caused by fire accumulations and six gatherings | |
| CN103083619B (en) | Traditional Chinese medicine composition for treating biliary tract ascariasis | |
| CN1879722A (en) | A medicine for treating rheumatic arthritis | |
| CN106177773B (en) | A kind of Chinese medicinal pill for treating calculi in urinary system | |
| CN100381142C (en) | A medicine for treating hepatitis | |
| CN104147209A (en) | Medicine for treating chronic pelvic inflammatory disease and application thereof | |
| CN102430057B (en) | Medicinal composition for treating rheumatic pain | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN101062340A (en) | Chinese traditional medicine combination good for liver for revovery | |
| CN105079487A (en) | Traditional Chinese medicine composition for treating heat stranguria | |
| CN105265786A (en) | Compound feed for cows and preparation method thereof | |
| CN101327312B (en) | Chinese herbal medicine for treating cholecystitis | |
| CN104721662A (en) | Chinese medicinal preparation for treatment of enterobiasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |